ABBV SEC Filings
SEC filings for ABBV. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 10-KAIAbbVie's MD&A is moderately positive: 9% revenue growth, Skyrizi and Rinvoq momentum, a favorable U.S. government agreement, a Moody's upgrade and a strong pipeline. | Feb 20, 2026 | 0001551152-26-000008EDGAR |
SEC filings for companies related to ABBV
Never miss a ABBV filing.
Get an email when ABBV files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.